These results affirm the notion that the effective concentrations required for the inhibition of ABC transporters are remarkably low in comparison to those determined for all tested human cell lines, thereby underscoring the potential safety of BEA in the context of leishmaniasis therapy. Here, ABCG2 is linked to leishmaniasis.